Keyword

CB-839

Description: A small-molecule inhibitor of glutaminase investigated as an anticancer agent by disrupting glutamine metabolism in tumor cells.
Wikidata ID: wiki/Q27075751
OpenAlex ID: keywords/cb-839
2014 · Matt I. Gross, Susan D. Demo, et al. · Molecular Cancer Therapeutics · 1,170
2016 · Amira Elgogary, Qingguo Xu, et al. · Proceedings of the National Academy of Sciences · 244
2018 · H. Furkan Alkan, Katharina E. Walter, et al. · Cell Metabolism · 222
2022 · Sarah A. Best, Patrick M. Gubser, et al. · Cell Metabolism · 202
2018 · Milica Momcilovic, Sean T. Bailey, et al. · Cancer Cell · 197
2019 · Mark A. Gregory, Travis Nemkov, et al. · Clinical Cancer Research · 192
2021 · Sruthy Varghese, Snigdha Pramanik, et al. · Molecular Cancer Therapeutics · 189
2019 · Elena S. Reckzeh, George Karageorgis, et al. · Cell chemical biology · 176
2018 · Jing Ge, Huachun Cui, et al. · American Journal of Respiratory Cell and Molecular Biology · 172
2017 · Milica Momcilovic, Sean T. Bailey, et al. · Cell Reports · 167
2017 · Ravyn M. Thompson, Dominik Dytfeld, et al. · Oncotarget · 132
2018 · Xi Xu, Ying Meng, et al. · Journal of Medicinal Chemistry · 124
2009 · W. Michael Caudle, Jing Zhang · Experimental Neurology · 124
2018 · Minsoo Song, Soong-Hyun Kim, et al. · Current Topics in Medicinal Chemistry · 123
2017 · Omran Abu Aboud, Samy L. Habib, et al. · Cancer Research · 119
2020 · L. Ren, V. Ruiz-Rodado, et al. · Cancer & Metabolism · 117
2019 · Gunnar Boysen, Azemat Jamshidi-Parsian, et al. · International Journal of Radiation Biology · 111
Works count: 490
Citation count: 11,460
Year
Topic
Type